Piedmont Investment Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-33,746
Closed -$581K 233
2020
Q1
$581K Buy
33,746
+1,525
+5% +$27.9K 0.02% 412
2019
Q4
$568K Sell
32,221
-3,949
-11% -$66.9K 0.02% 472
2019
Q3
$640K Sell
36,170
-1,970
-5% -$39.9K 0.02% 434
2019
Q2
$815K Buy
38,140
+8,561
+29% +$179K 0.03% 381
2019
Q1
$704K Buy
29,579
+421
+1% +$9.6K 0.03% 396
2018
Q4
$574K Buy
29,158
+7,928
+37% +$141K 0.03% 411
2018
Q3
$376K Buy
+21,230
New +$414K 0.02% 664

Other funds holding EXEL

Piedmont Investment Advisors's EXEL Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Exelixis (EXEL) in Q2 2020, closing a stake of 33,746 shares — an estimated $581K sold.

Piedmont Investment Advisors first reported a position in EXEL in Q3 2018 and held it in 7 quarters. The position peaked at $815K in Q2 2019. 375 funds tracked by Wall St. Rank hold EXEL as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Exelixis position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 33,746 Exelixis shares in Q2 2020, an estimated $581K.
  • Piedmont Investment Advisors first reported a position in Exelixis in Q3 2018 and held it in 7 quarters.
  • Piedmont Investment Advisors's Exelixis position peaked at $815K in Q2 2019.
  • 375 funds tracked by Wall St. Rank held Exelixis as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.